Condition
Allergic Bronchopulmonary Aspergillosis (ABPA) clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Allergic Bronchopulmonary Aspergillosis (ABPA) clinical trials that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest Allergic Bronchopulmonary Aspergillosis (ABPA) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ML-based ABPA recurrence predictor in adults with ABPA | — | Jinan, Shandong | Recruiting | Jul 20, 2026 |
| Fungal status and prognosis in ABPA: looking at who improves based on fungal tests | — | Jinan, Shandong | Recruiting | Jul 8, 2026 |
| Can a multi-omics and AI model predict ABPA relapse within 1 year in adults? | — | Jinan, Shandong | Recruiting | May 28, 2026 |
| Immune status and disease control in airway inflammatory diseases | — | Ningbo, Zhejiang | Recruiting | Mar 25, 2026 |
| Biologic treatment for adults with ABPA and severe asthma | — | Jinan, Shandong | Recruiting | Jan 23, 2026 |
| Bronchoscopic airway clearance with amphotericin B spraying for ABPA | — | Jinan, Shandong | Recruiting | Jan 23, 2026 |
| Inflammation types and molecular causes of allergic bronchopulmonary aspergillosis | — | Jinan, Shandong | Recruiting | Jun 27, 2025 |
All recruiting trials (7)
-
ML-based ABPA recurrence predictor in adults with ABPA
A machine-learning model is being tested to see if it can predict the chance of an ABPA flare within a year in adults with ABPA during a stable phase.
-
Fungal status and prognosis in ABPA: looking at who improves based on fungal tests
This study checks if ABPA patients with positive or negative fungal tests in sputum or BALF have different outcomes over a year.
-
Can a multi-omics and AI model predict ABPA relapse within 1 year in adults?
This study tests a machine learning model that uses multi-omics and clinical data to predict the 1-year relapse risk for adults with ABPA who are in a stable state.
-
Immune status and disease control in airway inflammatory diseases
This project will test whether specific blood immune cell patterns relate to disease control in adults with asthma, COPD, bronchiectasis, or obstructive sleep apnea by comparing them with healthy volunteers.
-
Biologic treatment for adults with ABPA and severe asthma
This project will test whether biologic medicines help adults with ABPA who have severe asthma and elevated eosinophils.
-
Bronchoscopic airway clearance with amphotericin B spraying for ABPA
This study will try bronchoscopic airway clearance plus amphotericin B spraying to see if it helps adults with allergic bronchopulmonary aspergillosis (ABPA) who have mucus plugs.
-
Inflammation types and molecular causes of allergic bronchopulmonary aspergillosis
This project will look for different inflammatory patterns and molecular biomarkers in people with ABPA to see if those patterns link to different clinical outcomes.
Related topics
Quick answers
How many Allergic Bronchopulmonary Aspergillosis (ABPA) clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.